Corning Inc led the $34 million Series B funding round for Cambridge, Massachusetts-based medical device maker NinePoint Medical Inc, a statement about the funding said.
Third Rock Ventures
Igenica Inc, the biopharmaceutical firm dedicated to developing antibodies and antibody-drug conjugates to treat the Big C, obtained $14 million in its Series C extension round.
Cambridge-based anti-obesity drug developer Zafgen Inc bagged another USD45 million in a Series E funding round today, bringing its total funding to date to USD114 million.
A consortium of venture capitalists had helped Editas Medicine raised USD43 million in Series A financing to create medicine designed to eradicate gene abnormalities.
Biopharmaceutical firm SAGE Therapeutics scored USD 20 million from ARCH Venture Partners and Third Rock Ventures in its Series B funding round.
Alcresta announced that it had raised US$10 million to accelerate production and commercialization of its drug that helps cancer patients.
bluebird bio today announced the successful completion of a $60 million Series D financing.
Subscribe to VCpost newsletter
Most Popular
- Former CEO Shoots Himself to Commit Suicide After Receiving $25 Million Record-Breaking Fine for Fraud at Steinhoff
- Xi Jinping Warns Dutch PM That 'No Force' Can Stop China's Technological Advancement Amid Export Restrictions
- Disney Investor Nelson Peltz Criticizes the Company’s 'Woke' Strategy, Questioning 'Black Panther' and 'The Marvels' Films
- Major AI Companies Unite to Create the World's First Artificial Superintelligence Alliance Worth $7.6 Billion
- Social Security Benefits to Increase for Some Seniors After Addressing Overpayment Issues
- Businessman Brutally Murdered Allegedly by 4 of His Workers Who Swung an Axe Into His Head
- North Korea Refuses Peace Talk With Japan Unless They Confront Their 'Brutal' History; Business Relations at Risk
- Hunter Biden Asks Court to Junk $1.4 Million Tax Evasion Case as Politically Motivated, But Judge Appears Skeptical